Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

David John Webb

Christison Professor of Therapeutics and Clinical Pharmacology

University of Edinburgh

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

10%

Cardiology

40%

Hypertension

50%

Rna Biology

40%

Endothelial Dysfunction

20%

Microrna Research

20%

Rna Interference

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Novel pharmacological approaches to lowering blood pressure and managing hypertension

Article Link

Year:

2025

Health technology assessment (HTA): Decisions on treatment efficiency guided by clinical judgement and pharmacoeconomics

Article Link

Year:

2025

Knowledge, attitudes, and practices related to hypertension among Sri Lankans: an online cross-sectional survey

Article Link

Year:

2025

Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension

Article Link

Year:

2024

Novel Pharmacological Approaches in the Treatment of Hypertension: A Focus on RNA-Based Therapeutics

Article Link

Year:

2023

Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment

Article Link

Year:

2023

Emerging insights and future prospects for therapeutic application of siRNA targeting angiotensinogen in hypertension

Article Link

Year:

2023

Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice

Article Link

Year:

2022

The effect of daily UVA phototherapy for 2 weeks on clinic and 24-h blood pressure in individuals with mild hypertension

Article Link

Year:

2022

Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review

Article Link

Year:

2022

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA

Article Link

Year:

2022

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial

Article Link

Year:

2022

Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease

Article Link

Year:

2021

Multi-layered Spatial Transcriptomics Identify Secretory Factors Promoting Human Hematopoietic Stem Cell Development

Article Link

Year:

2020

Chronotherapy in hypertension: the devil is in the details

Article Link

Year:

2020

Collaborators9

Martin Feelisch

University of Southampton

UNITED KINGDOM

Richard Weller

Reader

University of Edinburgh

UNITED KINGDOM

Neeraj Dhaun

University of Edinburgh

UNITED KINGDOM

Jessica Ivy

Lecturer

University of Edinburgh

UNITED KINGDOM

Peter Gallacher

SCREDS Clinical Lecturer in General Practice

University of Edinburgh

UNITED KINGDOM

Matthew Bailey

Professor of Renal Physiology

University of Edinburgh

UNITED KINGDOM

Kristina Kirschner

Reader/ Associate Professor

University of Glasgow

UNITED KINGDOM

Robert Hunter

Clinical Lecturer

University of Edinburgh

UNITED KINGDOM

Pierre-Louis Tharaux

Guest Professor

University Medical Center Hamburg-Eppendorf

GERMANY

How do I reach out?

Meet Kite AI